Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1995-05-01
2000-07-04
Woodward, Michael P.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 21, 530399, 424422, A61K 3816, A61K 3818
Patent
active
060839120
ABSTRACT:
Disclosed herein is a method for augmentation of soft tissue in an individual comprising administering percutaneously to the individual at a site for soft-tissue augmentation, a growth factor in an amount effective in eliciting a stable, localized growth of autologous vascularized adipose tissue. Applicable growth factors include IGF-I and IGF-II. The method is useful in treating soft tissue contour defects.
REFERENCES:
patent: 4774091 (1988-09-01), Yamahira et al.
patent: 5273900 (1993-12-01), Boyce
patent: 5308889 (1994-05-01), Rhee et al.
patent: 5723115 (1998-03-01), Serrero
Zezulak, K.M. et al. Science, 233 (4763), 551-553, Sep. 1986.
Butterwith, S.C. et al J. Endocrinol, 134(2), 163-168, Feb. 1992.
Campbell et al., Paradoxical lipodystrophic changes due to conventional bovine and highly purified porcine/bovine insulins, Postgraduate Medical Journal 60:439-441 (1984).
Lorenzo et al., IGF-I Is a Mitogen Involved in Differentiation-related Gene Expression in Fetal Rat Brown Adipocytes, J. of Cell Biology, 123, 6:1567-1575 (1993).
Breast Augmentation by Ilana Harman-Boehm, The Diabetes Care, vol. 12, No. 8, pp. 597-598, 1989.
The Influence of Dexamethasone on the Regrowth of Surgically Removed Fat by Angel et al., Ann Plast Surg 17:134-40 (1986).
In Vivo Metabolic Action of Insulin-Like Growth Factor I in Adult Rats, by Schmitz et al., Diabetologia, vol. 34, pp. 144-149, 1991.
Studies of Acute Effects of Insulin-Like Growth Factor I and II in Human Fat Cells, by Bolinder et al., Journal of Clinical Endocrinology and Metabolism, vol. 65, pp. 732-737, 1987.
How Distinct are the Insulin and Insulin-Like Growth Factor I Signalling Systems? by Adamo et al., BioFactors, vol. 3, No. 3, pp. 151-157, 1992.
Actions of Insulin-Like Growth Factors, by Froesch et al., Ann. Rev. Physiol., vol. 47, pp. 443-467, 1985.
Insulin-Like Growth Factor-I Is an Essential Regulator of the Differentiation of 3T3-L1 Adipocytes, by Smith et al., The Journal of Biol. Chem., vol. 263, No. 19, pp. 9402-9408, 1988.
Borin Michael
Khouri Roger K.
Woodward Michael P.
LandOfFree
Method for soft tissue augmentation does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for soft tissue augmentation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for soft tissue augmentation will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1486613